| Followers | 0 |
| Posts | 36 |
| Boards Moderated | 0 |
| Alias Born | 03/02/2006 |
Monday, March 13, 2006 1:47:30 PM
Scepticisms
I just thought I'd post a few ramblings to justify the userid that I chose for myself (near-randomly). One thing is to point readers to a blog called 'In the Pipeline', written by a guy who is doing chemical research at an unnamed drug company (http://pipeline.corante.com/). I've learned a few things from reading this... about once or twice a year there is something that is peripherally useful to me in my research. And how is it useful to all of you? Well, a few weeks ago he wrote a somewhat disparaging commentary about kinase inhibitors (with a pointer to an article about them which I didn't bother to read), concluding that we don't know enough about the biological pathways of the kinases to make good use of the inhibitors. And this may apply to INSM-18. I'm bringing this up because now and then someone will make some reference to the potential uses of this, and we are way premature in basing anything on it. Iplex has a seriously useful medium-term future and possible riches if it turns out to be useful for diabetes, burns or muscular dystrophy (and these look promising). But I don't think too much credence can yet be placed on INSM-18.
I guess that's enough rambling for today. Best wishes to all.
GS
I just thought I'd post a few ramblings to justify the userid that I chose for myself (near-randomly). One thing is to point readers to a blog called 'In the Pipeline', written by a guy who is doing chemical research at an unnamed drug company (http://pipeline.corante.com/). I've learned a few things from reading this... about once or twice a year there is something that is peripherally useful to me in my research. And how is it useful to all of you? Well, a few weeks ago he wrote a somewhat disparaging commentary about kinase inhibitors (with a pointer to an article about them which I didn't bother to read), concluding that we don't know enough about the biological pathways of the kinases to make good use of the inhibitors. And this may apply to INSM-18. I'm bringing this up because now and then someone will make some reference to the potential uses of this, and we are way premature in basing anything on it. Iplex has a seriously useful medium-term future and possible riches if it turns out to be useful for diabetes, burns or muscular dystrophy (and these look promising). But I don't think too much credence can yet be placed on INSM-18.
I guess that's enough rambling for today. Best wishes to all.
GS
Recent INSM News
- Insmed to Present at the 2026 Goldman Sachs Annual Global Healthcare Conference • PR Newswire (US) • 05/27/2026 11:00:00 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/22/2026 08:55:06 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/22/2026 08:25:21 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/20/2026 08:06:20 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/18/2026 08:53:52 PM
- Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers • Edgar (US Regulatory) • 05/15/2026 09:02:24 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 05/15/2026 09:00:08 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/15/2026 08:08:11 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/15/2026 08:08:02 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/15/2026 08:07:56 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/15/2026 08:07:43 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/15/2026 08:07:29 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/15/2026 08:07:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/15/2026 08:07:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/15/2026 08:07:09 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/15/2026 08:07:03 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/15/2026 08:06:55 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/15/2026 08:01:27 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/14/2026 09:20:30 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/13/2026 09:24:39 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/13/2026 09:18:59 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/13/2026 09:17:49 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/13/2026 09:17:24 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/13/2026 09:14:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/13/2026 08:50:00 PM
